Crystal Form Optimization
Crystal Form Optimization is a pharmaceutical engineering strategy that involves the systematic alteration of a drug's solid-state crystalline structure to enhance its solubility, stability, and ultimately its bioavailability.
224
Publications
11.6K
Citations
1K
Authors
353
Institutions
Publications per year
2017–2026
86
Parents
224
Pharmaceutical Cocrystals and Their Physicochemical Properties
N. Schultheiss, Ann Newman · Crystal Growth & Design · 2009 · 1.5K citations · Full text
1–5 of 224
1K
6
h-index
5
h-index
4
h-index
4
h-index
3
h-index
1–5 of 1K
353

University of Minnesota
Minneapolis, United States
7 h-index
20 publications
1.1K citations

Chinese Academy of Sciences
Beijing, China
6 h-index
17 publications
345 citations

University of Birmingham
Birmingham, United Kingdom
5 h-index
17 publications
586 citations
Jilin University
Changchun, China
5 h-index
27 publications
594 citations
Tianjin University
Tianjin, China
5 h-index
28 publications
742 citations
Pfizer (United States)
New York, United States
4 h-index
8 publications
405 citations
Cambridge Crystallographic Data Centre
Cambridge, United Kingdom
4 h-index
18 publications
1.7K citations

Indian Institute of Science Bangalore
Bengaluru, India
4 h-index
14 publications
612 citations
1–8 of 353
22 publications · 916 citations
16
h-index
18 publications · 2.2K citations
16
h-index
13 publications · 656 citations
13
h-index
8 publications · 554 citations
8
h-index
8 publications · 171 citations
8
h-index
1–5